Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05455905 · ClinicalTrials.gov registry record
Voice Biomarkers Predictive of Depression and Anxiety
A clinical trial, sponsored by Kintsugi Mindful Wellness.
- Completed
- Registry status
- 19,533
- Enrollment target
NCT05455905 is a clinical trial that has completed, run by Kintsugi Mindful Wellness. The registered enrollment target is 19,533 participants.
The verdict
NCT05455905 has completed, sponsored by Kintsugi Mindful Wellness.
- COMPLETED
- Registry status
- 19,533 participants
- Enrollment target
Study Summary
The objective of this study is to collect data to improve the sensitivity and specificity of Kintsugi Voice's (formerly KiVATM) predictions on audio files. A web-based audio recording tool will be used to record voice sample and ask participants the PHQ-9 and GAD-7 questions. A voluntary subset of participants will then be assessed by mental health professionals with the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A) scores.
Interventions
- DIAGNOSTIC_TEST Patient Health Questionnaire-9
- DIAGNOSTIC_TEST Generalized Anxiety Disorder-7
- DIAGNOSTIC_TEST Hamilton Depression Rating Scale
- DIAGNOSTIC_TEST Hamilton Anxiety Rating Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,533 participants |
| Start Date | 2021-09-14 |
| Est. Completion | 2022-09-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05455905
The ClinicalTrials.gov registry entry for NCT05455905 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19,533 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kintsugi Mindful Wellness, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Patient Health Questionnaire-9 is the first listed.
NCT05455905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05455905 about?
NCT05455905 is a clinical study titled "Voice Biomarkers Predictive of Depression and Anxiety". The objective of this study is to collect data to improve the sensitivity and specificity of Kintsugi Voice's (formerly KiVATM) predictions on audio files. A web-based audio recording tool will be used to record voice sample and ask participants the PHQ-9 and GAD-7 questions. A voluntary subset of p...
What is the current status of trial NCT05455905?
This trial is currently completed. The enrollment target is 19,533 participants. The study started on 2021-09-14. Estimated completion is 2022-09-11.
What interventions are being tested in trial NCT05455905?
The interventions under investigation include: Patient Health Questionnaire-9 (DIAGNOSTIC_TEST), Generalized Anxiety Disorder-7 (DIAGNOSTIC_TEST), Hamilton Depression Rating Scale (DIAGNOSTIC_TEST), Hamilton Anxiety Rating Scale (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05455905?
This trial is sponsored by Kintsugi Mindful Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.